News

​

Ask healthcare personnel what they need help with solving. Then match those needs with innovators, entrepreneurs and researchers that might already sit on a suitable solution or who could crack the issue faster with accelerated access to relevant insights and knowledgeable counterparts on the user end. This is the simple, but rather brilliant concept of Inn2Health.

Why should a digital health startup establish in Sweden? And how is the entrepreneur made to feel welcome?

Regional implementation is absolutely critical in making the Swedish national Life Science strategy a success. In a joint event with VGR and Lif, we took a closer look at the planned implementation in Region Västra Götaland - Sweden's largest region.

IRLAB discovers and develops new drugs for treatment of patients with Parkinson’s disease, using machine learning. Recently, their drug candidate mesdopetam got accepted by the US FDA's Investigational New Drug program (IND), enabling IRLAB to start human clinical trials in the US.

Respiratory diseases are one of the leading causes of death and disability in the world. PExA, part of Sahlgrenska Science Parks community, provides researchers with a technology to discover early signs of disease in the lungs – to enable treatment at an early stage and improve the outcome for the patient.